DCM
GRTS

DG Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

DG Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,000
Closed -$121K – 58
2022
Q2 		$121K Hold
50,000
– – 0.04% 30
2022
Q1 		$206K Buy
+50,000
New +$265K 0.04% 90
2021
Q4 		– Sell
-83,162
Closed -$898K – 156
2021
Q3 		$898K Buy
+83,162
New +$757K 0.18% 75

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

DG Capital Management's GRTS Position: Q3 2022 in Review

DG Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2022, closing a stake of 50,000 shares — an estimated $121K sold.

DG Capital Management first reported a position in GRTS in Q3 2021 and held it in 3 quarters. The position peaked at $898K in Q3 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q3 2022.

  • DG Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • DG Capital Management sold 50,000 Gritstone bio, Inc. Common Stock shares in Q3 2022, an estimated $121K.
  • DG Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • DG Capital Management's Gritstone bio, Inc. Common Stock position peaked at $898K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2022.

Based on DG Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.